Role of the IGF-II receptor in mediating acute, non-genomic effects of retinoids and IGF-II on keratinocyte cell death

Experimental Dermatology

Volumn 12, Issue 4, 2003, Pages 426-434

  Louafi, F ^a   Stewart, Claire E H ^a   Perks, C M ^a   Thomas, M G ^a   Holly, J M P ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Apoptosis; IGF II; IGF II receptor; Keratinocyte; Retinoic acid

Indexed keywords

CYCLOHEXIMIDE; INSULIN; RECOMBINANT SOMATOMEDIN B; RECOMBINANT SOMATOMEDIN C; RETINOIC ACID; RETINOID; SOMATOMEDIN B [27 LEUCINE]; SOMATOMEDIN B DERIVATIVE; SOMATOMEDIN B DES[1-6]; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN B RECEPTOR ANTAGONIST; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CELL DEATH; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; DRUG PROTEIN BINDING; DRUG RECEPTOR BINDING; FLOW CYTOMETRY; GENOME; HUMAN; HUMAN CELL; KERATINOCYTE; PROTEIN FUNCTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

APOPTOSIS; CELL DIVISION; CELL LINE; CYCLOHEXIMIDE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; KERATINOCYTES; MANNOSEPHOSPHATES; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECOMBINANT PROTEINS; TRETINOIN;

EID: 0041562559     PISSN: 09066705     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0625.2003.00080.x     Document Type: Article

References (28)

1. DiGiovanna J J. Systemic retinoid therapy. Dermatol Clin 2002: 19: 161-167.
2. Lotan R. Retinoids and chemoprevention of aerodigestive tract cancers. Cancer Metastasis Rev 1997: 16: 349-356.
3. Miller W H Jr. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer. Cancer 1998: 83: 1471-1482.
4. Kragballe K. The future of vitamin D in dermatology. J Am Acad Dermatol 1997: 37: S72-S76.
5. Torma H, Rollman O, Vahlquist A. The vitamin A metabolism and expression of retinoid-binding proteins differ in HaCaT cells and normal human keratinocytes. Arch Dermatol Res 1999: 291: 339-345.
6. Marikar Y, Wang Z, Duell E A, Petkovich M, Voorhees J J, Fisher G J. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells. J Invest Dermatol 1998: 111: 434-439.
7. Shang Y, Baumrucker C R, Green M H. Signal relay by retinoic acid receptors alpha and beta in the retinoic acid-induced expression of insulin-like growth factor-binding protein-3 in breast cancer cells. J Biol Chem 1999: 274: 18005-18010.
8. Miura H, Sano S, Higashiyama M, Yoshikawa K, Itami S. Involvement of insulin-like growth factor-I in psoriasis as a paracrine growth factor: Dermal fibroblasts play a regulatory role in developing psoriatic lesions. Arch Dermatol Res 2000: 292: 590-597.
9. Kang J X, Li Y, Leaf A. Mannnose-6-phosphate/insulin-like growth factor-II receptor is a receptor for retinoic acid. Proc Natl Acad Sci USA 1997: 94: 13671-13676.
10. Kornfeld S. Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors. Annu Rev Biochem 1992: 61: 307-330.
11. Clemmons D R, Jones J I, Busby W H, Wright G. Role of insulin-like growth factor binding proteins in modifying IGF actions. Ann N Y Acad Sci 1993: 692: 10-21.
12. DaCosta S A, Schumaker L M, Ellis M J. Mannose 6-phosphate/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate? J Mammary Gland Biol Neoplasia 2000: 5: 85-94.
13. Hankins G R, De Souza A T, Bentley R C et al. M6P/IGF2 receptor: A candidate breast tumor suppressor gene. Oncogene 1996: 12: 2003-2009.
14. Oates A J, Schumaker L M, Jenkins S B et al. The mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R), a putative breast tumor suppressor gene. Breast Cancer Res Treat 1998: 47: 269-281.
15. Godar S, Horejsi V, Weidle U H, Binder B R, Hansmann C, Stockinger H. M6P/IGFII-receptor complexes urokinase receptor and plasminogen for activation of transforming growth factor-beta1. Eur J Immunol 1999: 29: 1004-1013.
16. Roth B V, Burgisser D M, Luthi C, Humbel R E. Mutants of human insulin-like growth factor II. Expression and characterization of analogs with a substitution of TYR27 and/or a deletion of residues 62-67. Biochem Biophys Res Commun 1991: 181: 907-914.
17. Francis G L, Alpin S E, Milner S J, McNeil K A, Ballard F J, Wallace J C. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II. Biochem J 1993: 293: 713-719.
18. Fusenig N E, Boukamp P. Multiple stages and genetic alterations in immortalization, malignant transformation, and tumor progression of human skin keratinocytes. Mol Carcinog 1998: 23: 144-158.
19. Yateman M E, Claffey D C, Cwyfan Hughes S C, Frost V J, Wass J A, Holly J M. Cytokines modulate the sensitivity of human fibroblasts to stimulation with insulin-like growth factor-I (IGF-I) by altering endogenous IGF-binding protein production. J Endocrinol 1993: 137: 151-159.
20. Kang J X, Bell J, Beard R L, Chandraratna R A. Mannose 6-phosphate/insulin-like growth factor II receptor mediates the growth-inhibitory effects of retinoids. Cell Growth Differ 1999: 10: 591-600.
21. Blakesley V A, Stannard B S, Kalebic T, Helman L J, LeRoith D. Role of the IGF-I receptor in mutagenesis and tumor promotion. J Endocrinol 1997: 152: 339-344.
22. Hannun Y A. Functions of ceramide in coordinating cellular responses to stress. Science 1996: 274: 1855-1859.
23. Kang J X, Bell J, Leaf A, Beard R L, Chandraratna R A. Retinoic acid alters the intracellular trafficking of the mannose-6-phosphate/insulin-like growth factor II receptor and lysosomal enzymes. Proc Natl Acad Sci USA 1998: 95: 13687-13691.
24. Lonnroth P, Appell K C, Wesslau C, Cushman S W, Simpson I A, Smith U. Insulin-induced subcellular redistribution of insulin-like growth factor II receptors in the rat adipose cell. Counterregulatory effects of isoproterenol, adenosine, and cAMP analogues. J Biol Chem 1998: 263: 15386-15391.
25. Wardzala L J, Simpson I A, Rechler M M, Cushman S W. Potential mechanism of the stimulatory action of insulin on insulin-like growth factor II binding to the isolated rat adipose cell. Apparent redistribution of receptors cycling between a large intracellular pool and the plasma membrane. J Biol Chem 1984: 259: 8378-8383.
26. Xu S, Savage P, Burton J L, Sansom J, Holly J M. Proteolysis of insulin-like growth factor-binding protein-3 by human skin keratinocytes in culture in comparison to that in skin interstitial fluid: The role and regulation of components of the plasmin system. J Clin Endocrinol Metab 1997: 82: 1863-1868.
27. Liu B, Lee H Y, Weinzimer S A et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha regulate transcriptional signaling and apoptosis. J Biol Chem 2000: 275: 33607-33613.
28. Marinaro J A, Hendrich E C, Ledding K S, Bach L A. HaCaT human keratinocytes express IGF-II, IGFBP-6, and an acid-activated protease with activity against IGFBP-6. Am J Physiol 1999: 276: E536-E542.